T

TherapeuticsMD, Inc. (TXMD)

NMS – Real Time Price. Currency in USD

2.10

-0.12 (-5.41%)

At close: Mar 27, 2026, 4:00 PM EDT

2.10

0.00 (0.00%)

After-hours: Mar 27, 2026, 4:10 PM EDT

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

TherapeuticsMD, Inc. (TXMD)

NMS – Real Time Price. Currency in USD

2.10

-0.12 (-5.41%)

At close: Mar 27, 2026, 4:00 PM EDT

2.10

0.00 (0.00%)

After-hours: Mar 27, 2026, 4:10 PM EDT

12.11.2025

TherapeuticsMD Announces Third Quarter 2025 Financial Results

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the three months ended September 30, 2025. Third Quarter 2025 Financial Results Net Income (Loss) from Continuing Operations Net income from continuing operations was $50 thousand, or $0.00 per basic and diluted common share, compared to a net loss of $567 thousand, or $0.05 per basic and diluted.

Videos

No Data

There is no data to display

Press releases

12.11.2025

TherapeuticsMD Announces Third Quarter 2025 Financial Results

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the three months ended September 30, 2025. Third Quarter 2025 Financial Results Net Income (Loss) from Continuing Operations Net income from continuing operations was $50 thousand, or $0.00 per basic and diluted common share, compared to a net loss of $567 thousand, or $0.05 per basic and diluted.

TherapeuticsMD, Inc. (TXMD)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

TherapeuticsMD, Inc. (TXMD)

TherapeuticsMD Announces Third Quarter 2025 Financial Results

Videos

No Data

Press releases

TherapeuticsMD Announces Third Quarter 2025 Financial Results